MRC1 and cancer: MMR-deficient cancer cells have been shown to induce type I IFNs through activation of the cGAS–STING pathway by cytosolic DNA (Guan et al, 2021; Lu et al, 2021), but whether other DNA sensors or innate immune pathways are activated has not yet been studied.